Premium
The New FDA Pregnancy Labeling Requirements for Drugs
Author(s) -
Frederiksen Marilynn C.
Publication year - 2011
Publication title -
journal of midwifery and women's health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.543
H-Index - 62
eISSN - 1542-2011
pISSN - 1526-9523
DOI - 10.1111/j.1542-2011.2011.00067.x
Subject(s) - food and drug administration , drug labeling , pregnancy , medicine , drug , product (mathematics) , population , intensive care medicine , special populations , internet privacy , pharmacology , family medicine , computer science , environmental health , psychology , genetics , geometry , mathematics , biology , psychotherapist
The new US Food and Drug Administration Proposed Rules for pharmaceutical products for the special population of pregnant women were published in May 2008. With these new rules in place, clinicians caring for women who are pregnant may begin to have clearer and more relevant information in the product label to guide clinical decisions regarding drug use during pregnancy.